Manage subscriptions   |   FAQ   |   Report Bugs/Errors/Omissions to ors@sfu.ca
3 entries found

Canadian Glycomics Network (GlycoNet)

Sorry, no opportunities were found, please adjust your filters or try another search

20200915
150000

Canadian Glycomics Network (GlycoNet) - Translational Funding – 2020-2021 Canadian Verified Date 41 41 days until deadline

Deadline: September 15, 2020
Maximum Award: $150,000 CAD

The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence that focuses on the role of glycans (carbohydrates) in health. Areas of focus are neurodegenerative diseases, infectious diseases, chronic diseases, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer. These grants further advance/translate projects with proof of concept and protected IP.

20200915
150000

Canadian Glycomics Network (GlycoNet) - Strategic Initiatives 2020 - 2021 International Verified Date 41 41 days until deadline

Deadline: September 15, 2020
Maximum Award: $150,000 CAD

The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence that focuses on the role of glycans (carbohydrates) in health. Areas of focus are neurodegenerative diseases, infectious diseases, chronic diseases, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer.

20201001
50000

Canadian Glycomics Network (GlycoNet) - Clinical Partnerships 2020 - 2021 International Verified Date 57 57 days until deadline

Deadline: October 01, 2020
Maximum Award: $50,000 CAD

In this Request for Proposals, the Canadian Glycomics Network (GlycoNet) is seeking to fund Clinical Partnership projects that would offer clinicians and biomedical researchers opportunities to partner with Network Investigators to study glycans or glycosylation changes in disease. This partnership would increase clinician awareness of the role of glycomics in disease, and expand glycomics translational research and its application in more problems of clinical importance. Partnership outcomes could be better understanding of disease, drug development strategies, or new drug targets.


x